Ledger.Open graph →
SEC Form D · filed October 26, 2023

ADIAL PHARMACEUTICALS, INC

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Bankole A. Johnson · Charlottesville, VAExecJames K. Anderson · Charlottesville, VADirectorJames W. Newman, Jr · Charlottesville, VADirectorTony W. Goodman · Charlottesville, VADirectorRobertson H. Gilliland · Charlottesville, VADirectorCary J. Claiborne · Charlottesville, VAExec · DirectorKevin W. Schuyler, Cfa · Charlottesville, VADirectorJoseph M. Truluck · Charlottesville, VAExecW. C. Mccollum · Los Angeles, CAExecSever Totia · New York, NYDirectorJesse S. Jacobs · Playa Vista, CADirectorElaine Ellingham · Toronto, Ontario, CanadaExec · DirectorJason Bergsman · Playa Vista, CAExecMike Kerns · Playa Vista, CADirectorPeter Feld · New York, NYDirectorKweli Washington · New York, NYDirectorUrsula Newman · London, United KingdomExecThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecCory Brown · Nashville, TNDirectorLauren Smith · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorLee Hower · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗